CVM
NAMS icon

Cheviot Value Management’s NewAmsterdam Pharma NAMS Stock Holding History

Cheviot Value Management’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27K Hold
796
– – ﹤0.01% 246
2026
Q1 		$25.5K Hold
796
– – ﹤0.01% 235
2025
Q4 		$25.4K Hold
796
– – ﹤0.01% 243
2025
Q3 		$28.8K Hold
796
– – ﹤0.01% 244
2025
Q2 		$20.1K Buy
+796
New +$14.5K ﹤0.01% 244

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Cheviot Value Management's NAMS Position: Q2 2026 in Review

Cheviot Value Management held its NewAmsterdam Pharma (NAMS) position steady in Q2 2026 at 796 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #246.

Cheviot Value Management first reported a position in NAMS in Q2 2025 and has held it in 5 quarters since. The position peaked at $28.8K in Q3 2025. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Cheviot Value Management held 796 shares of NewAmsterdam Pharma worth $27K as of Q2 2026.
  • Cheviot Value Management left its NewAmsterdam Pharma share count unchanged in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #246 holding.
  • Cheviot Value Management first reported a position in NewAmsterdam Pharma in Q2 2025 and has held it in 5 quarters since.
  • Cheviot Value Management's NewAmsterdam Pharma position peaked at $28.8K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.